Coloplast (Germany) Performance
| CBHD Stock | EUR 66.00 0.36 0.55% |
The firm shows a Beta (market volatility) of -0.43, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Coloplast are expected to decrease at a much lower rate. During the bear market, Coloplast is likely to outperform the market. At this point, Coloplast AS has a negative expected return of -0.12%. Please make sure to confirm Coloplast's information ratio, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Coloplast AS performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Coloplast AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
Forward Dividend Yield 0.0469 | Payout Ratio 0.2674 | Last Split Factor 5:1 | Forward Dividend Rate 3.08 | Ex Dividend Date 2025-12-05 |
1 | Is Coloplast A S stock cheap vs fundamentals - Bear Alert Growth Focused Investment Plans - Newser | 12/04/2025 |
2 | Coloplast AS Hits New 12-Month Low - Should You Sell - MarketBeat | 02/09/2026 |
| Begin Period Cash Flow | 911 M | |
| Free Cash Flow | 1.4 B |
Coloplast |
Coloplast Relative Risk vs. Return Landscape
If you would invest 7,606 in Coloplast AS on November 28, 2025 and sell it today you would lose (1,006) from holding Coloplast AS or give up 13.23% of portfolio value over 90 days. Coloplast AS is producing return of less than zero assuming 4.8615% volatility of returns over the 90 days investment horizon. Simply put, 43% of all stocks have less volatile historical return distribution than Coloplast, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Coloplast Target Price Odds to finish over Current Price
The tendency of Coloplast Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 66.00 | 90 days | 66.00 | about 92.59 |
Based on a normal probability distribution, the odds of Coloplast to move above the current price in 90 days from now is about 92.59 (This Coloplast AS probability density function shows the probability of Coloplast Stock to fall within a particular range of prices over 90 days) .
Coloplast Price Density |
| Price |
Predictive Modules for Coloplast
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Coloplast AS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Coloplast's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Coloplast Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Coloplast is not an exception. The market had few large corrections towards the Coloplast's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Coloplast AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Coloplast within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.03 | |
β | Beta against Dow Jones | -0.43 | |
σ | Overall volatility | 4.24 | |
Ir | Information ratio | -0.04 |
Coloplast Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Coloplast for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Coloplast AS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Coloplast AS generated a negative expected return over the last 90 days | |
| Coloplast AS has high historical volatility and very poor performance | |
| About 30.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Coloplast AS Hits New 12-Month Low - Should You Sell - MarketBeat |
Coloplast Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Coloplast Stock often depends not only on the future outlook of the current and potential Coloplast's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Coloplast's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 225.3 M | |
| Dividends Paid | 4.7 B |
Coloplast Fundamentals Growth
Coloplast Stock prices reflect investors' perceptions of the future prospects and financial health of Coloplast, and Coloplast fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Coloplast Stock performance.
| Return On Equity | 0.27 | ||||
| Return On Asset | 0.0985 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 17.95 B | ||||
| Shares Outstanding | 207.37 M | ||||
| Price To Earning | 38.18 X | ||||
| Price To Book | 8.01 X | ||||
| Price To Sales | 0.53 X | ||||
| Revenue | 27.03 B | ||||
| Gross Profit | 18.93 B | ||||
| EBITDA | 8.58 B | ||||
| Net Income | 5.05 B | ||||
| Cash And Equivalents | 143.67 M | ||||
| Cash Per Share | 0.68 X | ||||
| Total Debt | 5.08 B | ||||
| Debt To Equity | 43.40 % | ||||
| Book Value Per Share | 8.21 X | ||||
| Cash Flow From Operations | 2.77 B | ||||
| Earnings Per Share | 2.37 X | ||||
| Total Asset | 48.07 B | ||||
| Retained Earnings | 15.39 B | ||||
About Coloplast Performance
By analyzing Coloplast's fundamental ratios, stakeholders can gain valuable insights into Coloplast's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Coloplast has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Coloplast has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Coloplast AS develops and markets intimate healthcare products and services worldwide. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. COLOPLAST NAM is traded on Frankfurt Stock Exchange in Germany.Things to note about Coloplast AS performance evaluation
Checking the ongoing alerts about Coloplast for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Coloplast AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Coloplast AS generated a negative expected return over the last 90 days | |
| Coloplast AS has high historical volatility and very poor performance | |
| About 30.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Coloplast AS Hits New 12-Month Low - Should You Sell - MarketBeat |
- Analyzing Coloplast's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Coloplast's stock is overvalued or undervalued compared to its peers.
- Examining Coloplast's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Coloplast's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Coloplast's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Coloplast's stock. These opinions can provide insight into Coloplast's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Coloplast Stock analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |